Mehabe score: 6 G Factor: 4 Piotski Score: 8 The stock has a rating . The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 4 and Piotski score of 8.
Description
Shankar Lal Rampal Dye-Chem is named as a prominent Trader, Exporter, Importer, and Supplier of Sulphur Dyes, Paraffin Wax, Phosphoric Acid, Sodium Sulphide, Hydrogen Peroxide, Citric Acid Monohydrate, Phosphate Chemicals, and Refined Glycerine, in India.(Source : Company Web-site)Site:542232Main Symbol:SRD
Stock trades at 62.6, below its 50dma 62.86. However it is trading above its 200dma 49.81. The stock remains weak in the short term due to near term bearish momentum. However overall bullish structure remains intact. Price action will further build up as it moves above its dma50, currently situated at 62.86.
The 52 week high is at 80.10 and the 52week low is at 30.98
Price Chart
P/E Chart
Sales and Margin
Strengths
– has reduced debt.
– has delivered good profit growth of 137.96% CAGR over last 5 years
Weakness
– has a low return on equity of 11.00% for last 3 years.
Competition
– The industry trades at a mean P/E of 49.7x. 3M India trades at the industry’s max P/E of 180.27x. 542232 trades at a P/E of 8.74x
– Industry’s mean G-Factor is 4.0 while the mean Piotski score is 8.0. 542232 has a G-Factor of 4 and Piotski scoreof 8.
– Average 1 month return for industry is -8.2%. The max 1- month return was given by Adani Enterp.: a return of 1.15 %
Quarterly Results
Sales for period ended Jun 2021 is Rs 54.93 cr compared to Rs 43.93 cr for period ended Mar 2020, a rise of 25.0%
Operating Profits reported at Rs 5.05 cr for period ended Jun 2021 vis-vis 3.99 for period ended Mar 2020 .
Operating Margins expanded 11.1 bps for period ended Jun 2021 vis-vis Mar 2020 .
The EPS for Jun 2021 was Rs 3.14 compared to Rs 2.52 for previous quarter ended Mar 2021 and Rs 2.37 for Mar 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 178.0 cr for period ended Mar 2021 vis-vis sales of Rs 133.0 cr for the period ended Mar 2020, a healthy growth of 25.3%. The 3 year sales cagr stood at 33.4%.
Operating margins expanded to 7.0% for period ended Mar 2021 vis-vis 4.0% for period ended Mar 2020, expansion of 300.0 bps.
Net Profit reported at Rs 8.0 cr for period ended Mar 2021 vis-vis sales of Rs 3.0 cr for the period ended Mar 2020, rising 62.5%.
Company recorded a healthy Net Profit CAGR of 100.0% over the last 3 years
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
CashFlow from operating activities was positive.
CashFlow from operating activities: Rs 10.0 cr for period ended Mar 2021 vis-vis Rs -6.0 cr for period ended Mar 2020
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 17.0% compared to 11.0% over the last 3 Years. – The stock has given a return of 87% on a 1 Year basis vis-vis a return of % over the last 3 Years. – The compounded sales growth on a TTM bassis is 34% vis-vis a compounded sales growth of 33% over the last 3 Years. – The compounded profit growth on a TTM basis is 184% vis-vis a compounded profit growth of 100% over the last 3 Years.
Ratios
Shareholding Pattern
– Public shareholding has remained largely constant. The Jun 2021 public holding stood at 26.49% vis-vis 26.49% for Mar 2021
Conclusion
– has reduced debt.
– has delivered good profit growth of 137.96% CAGR over last 5 years – has a low return on equity of 11.00% for last 3 years.
